|
|
||||||||
Journal of Applied Physiology, Vol 68, Issue 4 1494-1500, Copyright © 1990 by American Physiological Society
ARTICLES |
P. Thorborg, U. Gustafsson, F. Sjoberg, D. K. Harrison and D. H. Lewis
Department of Anesthesiology, University Hospital, Linkoping, Sweden.
Serotonin2 (5-HT2) receptor antagonists (ketanserin, ritanserin) can normalize a hyperoxemia-induced disturbance in skeletal muscle oxygenation, presumably by local microflow changes. The purpose of this study was to develop equipment for local hydrogen clearance measurements with a modified eight-channel platinum electrode to assess changes in local skeletal muscle capillary blood flow induced by hyperoxemia and ritanserin (0.035 mg/kg) during hyperoxemia. Laser-Doppler flowmetry was used for regional microflow measurements. Two groups of six anesthetized and artificially ventilated rabbits were studied: group I with normoxemia and hyperoxemia [arterial PO2 (PaO2) 48 kPa; 360 Torr] and group II before and after ritanserin with hyperoxemia (PaO2 46 kPa; 345 Torr). In group I, hyperoxemia induced a mean local hydrogen clearance decrease of 22% while laser-Doppler flowmetry signal decreased 31%. In group II, ritanserin induced a 125% mean local hydrogen clearance increase compared with hyperoxemia (or 37% compared with group I normoxemia); laser-Doppler flowmetry signal increased 30%. The sum distribution of local hydrogen clearances shifted to the left during hyperoxemia and to the right after ritanserin. The conclusion from this study is that local and regional microflow changes can explain the effects of hyperoxemia and ritanserin on skeletal muscle oxygenation.
This article has been cited by other articles:
![]() |
F. Toraman, S. Evrenkaya, S. Senay, H. Karabulut, and C. Alhan Adjusting Oxygen Fraction to Avoid Hyperoxemia During Cardiopulmonary Bypass Asian Cardiovasc Thorac Ann, August 1, 2007; 15(4): 303 - 306. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Johnston, L. A. Steiner, A. K. Gupta, and D. K. Menon Cerebral oxygen vasoreactivity and cerebral tissue oxygen reactivity{dagger} Br. J. Anaesth., June 1, 2003; 90(6): 774 - 786. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-O. Joachimsson, F. Sjoberg, M. Forsman, M. Johansson, H. C. Ahn, and H. Rutberg ADVERSE EFFECTS OF HYPEROXEMIA DURING CARDIOPULMONARY BYPASS J. Thorac. Cardiovasc. Surg., September 1, 1996; 112(3): 812 - 819. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |